Anavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The Moon

Barchart · 11/26 09:38
D. Boral Capital believes Anavex’s Alzheimer’s treatment is superior to Cassava Sciences' approach.